CXO, CMO, CDMO, CSO, CRO, how to distinguish these emerging terms in the pharmaceutical industry?

"CXO, CMO, CDMO, CSO and CRO" are new terms in pharmaceutical industry. In fact, many people are still relatively unfamiliar with them. They pay attention to industrial policy, which friends in the financial field may often see, but they still don't know much about it. Let's take you to distinguish them:

In fact, CXO is the general name of pharmaceutical outsourcing industry, which provides outsourcing services from research to production for innovative drugs introduced by pharmaceutical companies. According to the division of industrial chain, it is divided into CRO, CDMO and CMO.

CRO is the abbreviation of English contract research organization, in which the CRO model is called "contract R&D organization", which mainly focuses on outsourcing services in the R&D stage of innovative drugs. Because of different R&D processes, it can be divided into preclinical CRO CRO and clinical Cro. Because research and development is the most important and valuable part, this industry is generally replaced by CRO industry.

CMO, called "contract production organization", mainly focuses on the production outsourcing services in the later stage of innovative drug research and development, and is entrusted by pharmaceutical companies to provide services such as process development, dosage form development, intermediate manufacturing, preparation production and packaging required for product production. To put it bluntly, this is the foundry of innovative drugs.

CDMO, also known as "contract R&D and production organization", adds a production link in the R&D process, that is, from R&D to the production of innovative drugs, and further provides customized production services. But this is actually equivalent to a pharmaceutical foundry, only adding some technologies to research and development.

Translated into Chinese, CSO is a contract sales organization, which is a popular commercial organization abroad in recent years. It can provide comprehensive professional help for customer companies in the sales and marketing of products or services. Under the background of the new medical reform and the full implementation of the two-vote system in China, CSO model plays an extremely important role in the benign development of Chinese pharmaceutical enterprises.

The above are the differences of five new medical terms: "CXO, CMO, CDMO, CSO and CRO". Hope to help you, thank you for your continuous attention!